000 | 01310 a2200409 4500 | ||
---|---|---|---|
005 | 20250515132249.0 | ||
264 | 0 | _c20081118 | |
008 | 200811s 0 0 eng d | ||
022 | _a1555-8576 | ||
024 | 7 |
_a10.4161/cbt.7.7.6537 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWheeler, D L | |
245 | 0 | 0 |
_aErbB4 targeting approaches for prostate cancer treatment. _h[electronic resource] |
260 |
_bCancer biology & therapy _cJul 2008 |
||
300 |
_a1095-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xchemistry |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 |
_aErbB Receptors _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aProstatic Neoplasms _ximmunology |
650 | 0 | 4 | _aReceptor, ErbB-4 |
700 | 1 | _aRangnekar, Vivek M | |
700 | 1 | _aSchwarze, S R | |
773 | 0 |
_tCancer biology & therapy _gvol. 7 _gno. 7 _gp. 1095-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4161/cbt.7.7.6537 _zAvailable from publisher's website |
999 |
_c18171467 _d18171467 |